EUVIMED · CrossrefZeitschrift
Frontiers in Drug Safety and Regulation
ISSN 2674-0869 · Frontiers Media SA
Neueste Artikel
From signal detection to causal assessment: an evidence-based framework for integrated pharmacovigilance
From signal to mechanism: registry pharmacology and the future of translational pharmacovigilance
The effect of a peer-support collaboration among local pharmaceutical manufacturers in Uganda in strengthening pharmacovigilance systems: a qualitative case study
Does generative AI mean the “end of history” for pharmacovigilance automation? towards a framework for the future of human-AI systems
Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence
InfoMedex: drug-drug interaction prediction via a multimodal CNN-transformer model
Topical retinoids and risk of major congenital malformations and spontaneous abortion: a systematic review and meta-analysis
Safety profile of small interfering RNA therapeutics: a systematic review and meta-analysis of randomized controlled trials
Use of public health databases for the early identification of Autism spectrum disorder: a scoping review protocol
The cutaneous mirror: leveraging drug-induced skin phenotypes as early visual risk signals for systemic toxicity, a comprehensive review
Methodological comparisons for benefit-risk assessment in complex decision-making: applications and insights from a case study
Comprehensive pharmacovigilance assessment of pairwise drug–drug interactions and acute pancreatitis in the FDA adverse event reporting system: focus on incretin-based drugs
Evaluating the implementation of intermittent versus continuous fetal heart rate monitoring on intrapartum care and early neonatal outcomes using causal mediational modeling
Modafinil and abnormal bleeding in a young lady with narcolepsy: a case report
Strengthening pharmacovigilance and regulatory capacity in Southern Africa (SPaRCS): achievements, experiences and lessons learned from a participatory action learning project
Outcomes of post-approval non-interventional safety studies in pregnancy: wide variation demonstrates need for further standardization
Global pharmacovigilance reporting: comparative analysis of adverse event obligations across five major regulatory authorities
Editorial: Pandemic preparedness in vaccine safety and regulation
Physiological actions of “medical devices made of natural materials” (such as vegetal matrices) and non-pharmacological actions of “medical devices made of substances” (and as such artificial derivatives) as innovations introduced by Regulation 2017/745
Risk of neurodevelopmental disorders after fetal topiramate exposure: a systematic review
Tokenization techniques for privacy-preserving healthcare data: tokenization nuts and bolts
Discrepancies in regulations in post-marketing safety surveillance of drug-device combination products in the EU and US: a review
Leveraging real-world data for safety signal detection and risk management in pre- and post-market settings
Communicating medication risks in pregnancy: Towards shared decision making
Federated learning: a privacy-preserving approach to data-centric regulatory cooperation
Achieving synchrony: bridging the gap between pharmaceutical companies and regulators on safety labeling updates
Measurement error and bias in real-world oncology endpoints when constructing external control arms
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?
Aspects to consider in causality assessment of safety signals: broadening the thought process
EUVIMED